Emicizumab-kxwh Subcutaneous and Fosaprepitant
Determining the interaction of Emicizumab-kxwh Subcutaneous and Fosaprepitant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Fosaprepitant Injection
- Emicizumab-kxwh Subcutaneous-Fosaprepitant Intravenous
- Emicizumab-kxwh Subcutaneous-Foscarnet
- Emicizumab-kxwh Subcutaneous-Foscarnet Intravenous
- Emicizumab-kxwh Subcutaneous-Foscarnet Sodium
- Emicizumab-kxwh Subcutaneous-Foscavir
- Fosaprepitant-Emla
- Fosaprepitant-Emla Topical
- Fosaprepitant-Emo-Cort Scalp Solution Topical application
- Fosaprepitant-Emo-Cort Topical application
- Fosaprepitant-Emoquette
- Fosaprepitant-Empagliflozin